Status:
COMPLETED
Endoscopic Ultrasound Guided Liver Biopsy
Lead Sponsor:
AdventHealth
Conditions:
Hepatic Cancer
Hepatic Neoplasm
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This is a prospective study to determine the optimal technique for obtaining liver tissue with a smaller caliber (22 gauge) needle and whether a good core biopsy can be obtained without the use of suc...
Detailed Description
Liver biopsy (LB) has historically been performed by percutaneous route without image guidance (blind biopsy). However, in the last several years there has been more reliance on image guidance ultraso...
Eligibility Criteria
Inclusion
- All patients referred to Florida Hospital Endoscopy Unit for assessment of elevated liver tests with EUS and are found to have no obstructive lesion to explain elevation of liver tests and will not require ERCP.
- Age ≥ 19 years
- Willing to provide informed consent verbal or written.
Exclusion
- Age \<19 years
- Unable to safely undergo EUS for any reason
- Coagulopathy (INR \>1.6, Thrombocytopenia with platelet count \<50,000/ml) for subjects on anti-coagulation therapy.
- Unwilling or cognitively unable to provide informed consent verbal or written.
- Pregnancy (confirmed with Standard of Care urine pregnancy test for all women with child-bearing potential only)
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03307811
Start Date
August 1 2017
End Date
October 1 2018
Last Update
February 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Interventional Endoscopy - Florida Hospital
Orlando, Florida, United States, 32803